Europeanhhm

Beckman Coulter Integrates Scopio Labs Digital Cell Morphology with Hematology Workcell for Enhanced Automated Workflow

Thursday, July 20, 2023

Beckman Coulter, a renowned clinical diagnostics leader, has unveiled its latest innovation at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo. The solution showcases the integration of Beckman Coulter's DxH 900 Workcell and DxH Slidemaker Stainer II with Scopio Labs' digital morphology platform, offering end-to-end digitization with AI-assisted peripheral blood smear analysis.

The collaboration between Beckman Coulter and Scopio Labs enables the automatic transfer of peripheral blood smear (PBS) slides from the DxH Slidemaker Stainer II to the Scopio X100HT platform. This seamless transfer streamlines the PBS analysis process, eliminating the need for manual slide transfer and enabling continuous loading, scanning, and analysis.

Dan Xu, Vice President/GM of Hematology and Urinalysis Business Units for Beckman Coulter, emphasized the significance of accurate and timely PBS results in diagnosing and treating hematological disorders and malignancies. The integrated system empowers medical technicians with efficient lab operations and Scopio's Full-Field technology obviates the need for manual review under a microscope.

Itai Hayut, CEO and Co-Founder of Scopio Labs, expressed enthusiasm for advancing their partnership with Beckman Coulter. The fully integrated hematology workflow, from complete blood count (CBC) test to slide staining (SMS) to PBS, enhances the detection of blood-related medical conditions by qualified experts.

Scopio Labs' X100HT device, cleared by the U.S. Food and Drug Administration (FDA) with its PBS Application in 2022, brings together high-throughput capabilities and high-resolution scanning for hematological analysis. With the ability to process up to 30 samples per hour, the X100HT meets the demands of large hospitals and labs while supporting remote review capabilities. Additionally, the previously-cleared X100 instrument, with a 3-slide tray and a throughput of up to 15 slides per hour for a 200 WBC Diff, caters to small to medium-size laboratories. This combination of innovative solutions addresses the needs of medical facilities and labs worldwide, revolutionizing hematology analysis with AI-assisted technology.

https://www.prnewswire.com/news-releases/beckman-coulter-connects-scopio-labs-digital-cell-morphology-with-hematology-workcell-extending-automated-workflow-301880438.html

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024